Abstract
Facilitated Subcutaneous Immunoglobulin 10% for CIDP: Interim Results from a Long-term Safety and Tolerability Study (S15.007)
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
